Legacy Wealth Asset Management, LLC Bei Gene, Ltd. Transaction History

Legacy Wealth Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$248.56 - $389.34 $153,112 - $239,833	-616 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$249.6 - $403.14 $3,744 - $6,047	15 Added 2.5%	616 $224,000
Q2 2021 Jul 14, 2021	BUY	$292.75 - $367.01 $3,220 - $4,037	11 Added 1.86%	601 $206,000
Q1 2021 Apr 20, 2021	BUY	$260.64 - $382.12 $153,777 - $225,450	590 New	590 $205,000

216

45.1M

76.5K

72.3K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $15.3B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Legacy Wealth Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Legacy Wealth Asset Management, LLC with notifications on news.